Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Meet the people who want peptides to be made in America

    12. November 2026

    Access denied — Trend Hunter

    12. November 2026

    Whoop rolls out ‚Humans‘ upgrade for subscribers — Strava-like feature promises to be ‚most verifiably human‘ social network

    12. November 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Siemens Healthineers predicts tariff impact will double
    News

    Siemens Healthineers predicts tariff impact will double

    HealthradarBy Healthradar6. November 2025Keine Kommentare3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Siemens Healthineers predicts tariff impact will double
    Share
    Facebook Twitter LinkedIn Pinterest Email


    By the numbers

     

    Q4 Revenue: 6.32 billion euros

    Roughly flat year over year

     

    Net income: 597 million euros

    4% decrease year over year

    Siemens Healthineers has reaffirmed its expectation that the negative impact of tariffs will double in its next fiscal year to reach 400 million euros (nearly $461 million).

    With tariffs coming in part way through the company’s financial year, executives forecast in July that the impact would be 200 million to 250 million euros in its fiscal 2025 and 400 million euros to 500 million euros in fiscal 2026. Siemens updated its figures Wednesday as part of its fourth-quarter results. With the final tariff hit for the 2025 fiscal year totaling 200 million euros, the company is predicting a 400 million euro impact for fiscal 2026.

    CFO Jochen Schmitz said on the fourth-quarter earnings call that he expects 2026 to be the year the tariff effect is most notable. Provided the current tariff regime stays in place, the company expects the net impact of tariffs to decrease year-on-year as Siemens’ countermeasures take effect. In the medium term, Schmitz expects Siemens to fully offset the negative effects of tariffs.

    “With our global production setup and our strong presence in the U.S. and other countries, we have every opportunity to shift parts of our value creation if needed. We are examining the options available to us,” the CFO said at the company’s annual press conference for fiscal 2025. “However, we will take action only once there is sufficient planning certainty and it makes economic sense.” 

    A focus on making equipment at centers with specialized expertise constrains Siemens‘ ability to relocate manufacturing. Schmitz cited the production of superconducting magnets for MRI body scanners in Oxford, U.K., as one of several examples of Siemens manufacturing operations being tied to expertise in a location.

    CEO Bernd Montag named the company’s photon-counting center as another example of an activity that is tied to a specific place. The CEO said on the media call that trying to replicate the site elsewhere would “lose efficiency” and make everything more expensive. 

    “That is why it is a deplorable development that global companies, that have to be global per se … are basically caught up in this trade war whirlpool,” Montag said.

    Higher tariffs hurt all Siemens’ businesses in the fourth quarter. For fiscal 2026, the company is forecasting that tariffs will pressure margins at its imaging and advanced therapies businesses. The company expects Varian and its diagnostics business to be less impacted by tariffs than other units. Tariff projections reflect the location of Siemens’ manufacturing sites.



    Source link

    double Healthineers Impact Predicts Siemens tariff
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleThe Fitbit Charge 6 is back to its lowest price ever for Black Friday
    Next Article Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Reshoring prompts crucial decisions for medical device manufacturers

    26. Oktober 2026
    News

    Developers, not doctors, should be held accountable for generative AI medical devices, providers say

    23. Oktober 2026
    News

    FDA-Cleared AI Stethoscope Unifying Traditional and Digital Listening for Adult and Pediatric Care

    23. Oktober 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 20251.116 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 20251.105 Views

    The 4.5-star-rated Google Pixel Watch just fell back to its Black Friday price on Amazon

    26. Mai 2026270 Views

    Luna ring review | TechRadar

    26. Dezember 2025236 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 20251.116 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 20251.105 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.